BriaCell Enters Research Agreement to Identify Novel Targets for Cancer Treatment Pharmaceutical Investing
The Gummy Project Announces Another Milestone with Entry into Canadian Retail Market Life Science Investing
Mindset Pharma Announces Development of Novel, Optimized, Intranasal Formulation Life Science Investing
Ambrx Biopharma Inc. to Present at the H.C. Wainwright Preclinical Cancer Drug Discover Conference Life Science Investing
Health Canada Approves OPDIVO® as Monotherapy for the Adjuvant treatment of Adults with Urothelial Carcinoma at High Risk of Recurrence after Undergoing Radical Resection of UC Pharmaceutical Investing
Kite's CAR T-cell Therapy Yescarta® Granted European Marketing Authorization for the Treatment of Relapsed or Refractory Follicular Lymphoma Pharmaceutical Investing
Gilead Resubmits New Drug Application to U.S. Food and Drug Administration for Lenacapavir, an Investigational, Long-Acting HIV-1 Capsid Inhibitor Pharmaceutical Investing
Cardiol Therapeutics to Webcast Virtual Annual General Meeting on June 28th at 4:30 P.M. EDT Pharmaceutical Investing
Gilead Endorses The Kigali Declaration On Preventing, Controlling and Eliminating Neglected Tropical Diseases Pharmaceutical Investing
Approximately 15,000 AbbVie Employees to Volunteer Globally to Support Local Communities in Annual Week of Possibilities Pharmaceutical Investing
